Αποτελέσματα Αναζήτησης
30 Σεπ 2024 · Blackstone Life Sciences (BXLS) is a platform that combines capital and expertise to fund and advance innovative medicines and technologies. BXLS collaborates with leading life science companies, such as Moderna, Alnylam and Sanofi, and has brought 147 medicines to market.
4 Οκτ 2018 · Blackstone announced in 2018 that it had agreed to buy Clarus, a global firm that funds growth-stage biopharmaceutical companies. The acquisition launched Blackstone Life Sciences, a private investment platform with expertise and scale to advance breakthrough products.
30 Νοε 2018 · Blackstone completes the acquisition of Clarus, a global life sciences investment firm, and launches Blackstone Life Sciences. The new platform will invest across the life-cycle of companies and products in biopharmaceutical, medical device and diagnostic sectors.
Clarus Ventures is a life sciences venture capital firm founded by a team of accomplished investment professionals with extensive and complementary industry backgrounds which have enabled them to establish a long history of success in creating value.
4 Οκτ 2018 · Blackstone Group, the world’s largest private equity firm, has agreed to buy Clarus Ventures, an investment firm with $2.6 billion of assets, to create Blackstone Life Sciences. The deal aims to fill a funding gap in the life sciences industry and collaborate with biopharmaceutical companies in research and development.
Clarus Funds is a global investment firm dedicated to life sciences, with offices in Cambridge, MA and South San Francisco, CA. It manages over $2.6 billion and has invested in over 50 biotechnology, medical device and diagnostic companies.
4 Οκτ 2018 · Blackstone, a private equity giant with $440 billion in assets, has acquired Clarus, a life sciences venture capital firm. The deal aims to fill the funding gap for biopharma companies that need big money to run late-phase trials and seek partners or exits.
